Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/21/2016
Zai Lab Picks Up Two GSK Anti-Inflammatory Assets
10/21/2016
MicuRx Initiates Phase 3 Trial for New Potent Oral Antibiotic MRX-I
10/20/2016
Upcoming Event: International Conference and Exhibition on Nanomedicin...
10/20/2016
India Agitated by Large Scale API Import from China, Calling to Raise ...
10/20/2016
Recent Executive Moves
10/20/2016
Hisun Pharma Gets ANDA Approval from the USFDA
10/20/2016
New Study - Asia Pacific Breast Cancer Market to Grow at CAGR of 8.5% ...
10/20/2016
Critical Illness Insurance Now Covers 1.05 Bln Urban and Rural Residen...
10/19/2016
CFDA Solicits Public Comments on Biochemical Drug Appendix of GMP
10/18/2016
CStone's Files IND for PD-L1 Monoclonal Antibody with the CFDA
10/18/2016
How To Think About China's Special Economic Zones As A Foreign Pharmac...
10/18/2016
CFDA Solicits Public Comments on Three Appendices of GSP
10/18/2016
CFDA Solicits Public Comments on Cleanup of Past Official Documents
10/18/2016
Zhejiang and Shaanxi Relaxes Non-Essential Drug Inventory Limit in Pri...
10/18/2016
Guangdong Introduces New Action Plan for Healthcare Cost Containment
10/17/2016
Hua Medicine Announces First-Ever Successful Phase II Monotherapy Tria...
10/17/2016
TOT Biopharma Begins Phase II Construction of Its mAb Facility in Suzh...
10/17/2016
Fujifilm to Invest HK$806M in China Resources Pharma
10/17/2016
GSK Ramps Up Neuroscience R&D in China Thru Local Partnerships
10/14/2016
NHFPC, MOF Issue Official Notice to Link Negotiation Outcome and NRCMS...
10/14/2016
Data Snapshot: Urban Public Hospital Market for Chemical Drugs
10/14/2016
National Cancer Center Releases Official Chinese Cancer Prevalence Dat...
10/14/2016
Five Central Government Agencies Issues Two Health Science & Techn...
10/14/2016
Novartis Cuts More R&D Jobs, Closing Chinese and Swiss Locatio...
10/13/2016
Kymab, EpimAb Enter Multi-Target, Bispecific Antibody Cross-Licensing ...
10/13/2016
Green Cross Refocuses on China As It Halts US Trials of Hemophilia Dru...
10/13/2016
TransThera Biosciences Raises $10M in Round A to Develop Novel NCE Dru...
10/13/2016
FDA Bans Import from Another Chinese Drug Manufacturer
10/13/2016
Certara Establishes Phoenix PK/PD Centers of Excellence in China and J...
10/13/2016
Recent Executive Moves
Page:
331
/
720
Total number of articles:
21594
:
[First]
[<<]
[329]
[330]
[331]
[332]
[333]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit